Amneal Pharmaceuticals has launched Escitalopram Oxalate Oral Solution in 5-mg/5-mL strength, the first generic of antianxiety/antidepressant Lexapro (Forest) in liquid form on the market. .
Amneal Pharmaceuticals has launched escitalopram oxalate oral solution in 5 mg/5 mL strength, the first generic of antianxiety/antidepressant Lexapro (Forest) in liquid form on the market.
Annual U.S. sales of Lexapro Oral Solution are $7.3 million, according to December 2011 IMS Health market data.
Escitalopram oxalate oral solution is available in an 8-fl. oz./240-mL bottle that does not require refrigeration. The clear, pale yellow liquid comes in peppermint flavor.
“As a first-to-market generic, escitalopram oxalate oral solution provides a significantly less-expensive alternative to the brand pharmaceutical, especially for patients in hospitals and managed care who cannot swallow oral solids,” Chirag Patel, Amneal’s president, told Drug Topics. “This product helps reduce expenses for the patient, reduces the overall cost of healthcare, and improves pharmacy margins. Everyone gains in that equation.”
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.